{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T10:11:52Z","timestamp":1777198312946,"version":"3.51.4"},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-16-0121","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T22:15:46Z","timestamp":1467152146000},"page":"1916-1921","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of Chronic Angioscopic Findings of Bare Metal Stents, 1st-Generation Drug-Eluting Stents and 2nd-Generation Drug-Eluting Stents\u3000\u2013 Multicenter Study of Intra-Coronary Angioscopy After Stent (MICASA) \u2013"],"prefix":"10.1253","volume":"80","author":[{"given":"Kazuoki","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hiroshima City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ehime Prefectural Imabari Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ehime Prefectural Imabari Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okayama Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Matsuyama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Nakama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Division of Coronary Heart Disease, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Homes DR, O\u2019Shaughnessy C, et al; for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. <i>N Engl J Med<\/i> 2003; 349: 1315\u20131323.","DOI":"10.1056\/NEJMoa035071"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Perin M, et al; for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. <i>N Engl J Med<\/i> 2002; 346: 1773\u20131780.","DOI":"10.1056\/NEJMoa012843"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kyung WP, Si HK, Woo YC, Hae YL, Jin SP, Hyun JK, et al. \u2018Real World\u2019 comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction. <i>Circ J<\/i> 2010; 74: 1111\u20131120.","DOI":"10.1253\/circj.CJ-09-0936"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. <i>Lancet<\/i> 2007; 369: 667\u2013678.","DOI":"10.1016\/S0140-6736(07)60314-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. <i>Lancet<\/i> 2004; 364: 1519\u20131521.","DOI":"10.1016\/S0140-6736(04)17275-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, et al. Impact of the everolimus-eluting stent on stent thrombosis: A meta-analysis of 13 randomized trials. <i>J Am Coll Cardiol<\/i> 2011; 58: 1569\u20131577.","DOI":"10.1016\/j.jacc.2011.06.049"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D\u2019Ascenzo F, et al. Stent thrombosis with drug-eluting and bare-metal stents: Evidence from comprehensive network meta-analysis. <i>Lancet<\/i> 2012; 379: 1393\u20131402.","DOI":"10.1016\/S0140-6736(12)60324-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Stefanini GG, Byrne RA, Serruys PW, Waha AD, Meier B, Massberg S, et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: A pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. <i>Eur Heart J<\/i> 2012; 33: 1214\u20131222.","DOI":"10.1093\/eurheartj\/ehs086"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Waha AD, Cassese S, Park DW, Burzotta F, Byrne RA, Tada T, et al. Everolimus-eluting versus sirolimus-eluting stents: An updated meta-analysis of randomized trials. <i>Clin Res Cardiol<\/i> 2012; 101: 461\u2013467.","DOI":"10.1007\/s00392-012-0414-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Raber L, Margo M, Stefanini GG, Kalesan B, Domburg RT, Onuma Y, et al. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: A prospective cohort study. <i>Circulation<\/i> 2012; 125: 1110\u20131121.","DOI":"10.1161\/CIRCULATIONAHA.111.058560"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tada T, Byrne RA, Simunovic I, King LA, Cassesse S, Joner M, et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents. <i>J Am Coll Cardiol Interv<\/i> 2013; 6: 1267\u20131274.","DOI":"10.1016\/j.jcin.2013.06.015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Akazawa Y, Matsuo K, Ueda Y, Nishio M, Hirata A, Asai M, et al. Atherosclerotic change at one year after implantation of Endeavor zotarolimus-eluting stent vs. everolimus-eluting stent. <i>Circ J<\/i> 2014; 78: 1428\u20131436.","DOI":"10.1253\/circj.CJ-14-0085"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Dai K, Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, et al. Coronary angioscopic findings eight months after sirolimus-eluting stent implantation: A comparison between ST-elevation myocardial infarction and stable angina pectoris. <i>Euro Intervention<\/i> 2010; 6: 251\u2013256.","DOI":"10.4244\/EIJV6I2A40"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Heifer PD, Foley DP, Hillege HL, Lablanche JM, Dijk RBV, Franzen D, et al. The \u201cErmenonville\u201d classification of observations at coronary angioscopy: Evaluation of intra- and inter-observer agreement. <i>Eur Heart J<\/i> 1994; 15: 815\u2013822.","DOI":"10.1093\/oxfordjournals.eurheartj.a060590"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Palmerini T, Benedetto U, Zoccai GB, Riva DD, Reggiani LB, Smits PC, et al. Long-term safety of drug-eluting and bare-metal stents. <i>J Am Coll Cardiol<\/i> 2015; 65: 2496\u20132507.","DOI":"10.1016\/j.jacc.2015.04.017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. <i>Circulation<\/i> 2014; 129: 211\u2013223.","DOI":"10.1161\/CIRCULATIONAHA.113.001790"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. <i>Circulation<\/i> 2007; 115: 2435\u20132441.","DOI":"10.1161\/CIRCULATIONAHA.107.693739"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants. <i>J Am Coll Cardiol<\/i> 2011; 57: 1314\u20131322.","DOI":"10.1016\/j.jacc.2011.01.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Inoue T, Shinke T, Otake H, Nakagawa M, Hariki H, Osue T, et al. Neoatherosclerosis and mural thrombus detection after sirolimus-eluting stent implantation: Comparison of angioscopy and optical coherence tomography assessment for color-based tissue characterization. <i>Circ J<\/i> 2014; 78: 92\u2013100.","DOI":"10.1253\/circj.CJ-13-0374"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ueda Y, Matsuo K, Nishimoto Y, Sugihara R, Hirata A, Nemoto T, et al. In-stent yellow plaque at 1 year after implantation is associated with future event of very late stent failure. <i>J Am Coll Cardiol Interv<\/i> 2015; 8: 814\u2013821.","DOI":"10.1016\/j.jcin.2014.12.239"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: Comparison with bare-metal stents. <i>Circulation<\/i> 2007; 116: 910\u2013916.","DOI":"10.1161\/CIRCULATIONAHA.105.609057"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hara M, Nishino M, Taniike M, Makino N, Kato H, Egami Y, et al. Difference of neointimal formational pattern and incidence of thrombus formation among 3 kinds of stents: An angioscopic study. <i>J Am Coll Cardiol Interv<\/i> 2010; 3: 215\u2013220.","DOI":"10.1016\/j.jcin.2009.10.031"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Dai K, Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Miura F, et al. Coronary angioscopic findings 9 months after everolimus-eluting stent implantation compared with sirolimus-eluting stents. <i>J Cardiol<\/i> 2013; 61: 22\u201330.","DOI":"10.1016\/j.jjcc.2012.08.011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Choi HH, Kim JS, Yoon DH, Hong KS, Kim TH, Kim BK, et al. Favorable neointima coverage in everolimus-eluting stent at 9 months after stent implantation: Comparison with sirolimus-eluting stent using optical coherence tomography. <i>Int J Cardiovasc Imaging<\/i> 2012; 28: 491\u2013497.","DOI":"10.1007\/s10554-011-9849-7"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/9\/80_CJ-16-0121\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:22:10Z","timestamp":1498324930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/9\/80_CJ-16-0121\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-16-0121","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}